Mirko Doni

*Email*	[email protected]
*Telephone*	+390294375115
*Location*	Building 13 Floor Ground Via Adamello 16, Milano

Member of

Viruses and Cancer - Technician

After a Master Degree in Medicinal Chemistry and Pharmaceutical Technology with a research internship on cardiovascular diseases at Istituto di Ricerche Farmacologiche Mario Negri, I have attended a Master in Pharmaceutical and Healthcare Management that helped me in expanding my view on healthcare system and understanding the socio-economic impact of research results.
Since 2004, I have been working as Research Assistant in the Department of Experimental Oncology, at the European Institute of Oncology, with focus on lymphoma and hepatocellular carcinoma models.
During these 15 years, I have supported many researchers at different levels from undergraduates to senior post-docs, helping them during their everyday research activities leading to several publications in peer reviewed top journals where my contribution was acknowledged with authorship.

Most Relevant Publications

Rava' M, D'Andrea A, Nicoli P, Gritti I, Donati G, Doni M, Giorgio M, Olivero D, Amati B

Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.

Sci Transl Med, 2018
Rava' M, D'Andrea A, Doni M, Kress TR, Ostuni R, Bianchi V, Morelli MJ, Collino A, Ghisletti S, Nicoli P, Recordati C, Iascone M, Sonzogni A, D'Antiga L, Shukla R, Faulkner GJ, Natoli G, Campaner S, Amati B

Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.

Hepatology, 2017
Sabò A, Kress TR, Pelizzola M, de Pretis S, Gorski MM, Tesi A, Morelli MJ, Bora P, Doni M, Verrecchia A, Tonelli C, Fag G, Bianchi V, Ronchi A, Low D, Mller H, Guccione E, Campaner S, Amati B

Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.

Nature, 2014
Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D, Schleker T, Perna D, Tronnersjö S, Murga M, Fernandez-Capetillo O, Barbacid M, Larsson LG, Amati B

Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Nat Cell Biol, 2010

Mirko Doni

Mirko Doni

Most Relevant Publications

Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.

Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.

Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.

Cdk2 suppresses cellular senescence induced by the c-myc oncogene.